AVITA Medical Inc RCEL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/24/21 EDT
18.21UNCH (UNCH)
Volume
905
Close
18.21quote price arrow down-0.18 (-0.98%)
Volume
47,375
52 week range
16.52 - 28.49
Loading...
  • Open18.31
  • Day High18.43
  • Day Low18.12
  • Prev Close18.39
  • 52 Week High28.49
  • 52 Week High Date01/26/21
  • 52 Week Low16.52
  • 52 Week Low Date08/17/21

Key Stats

  • Market Cap453.43M
  • Shares Out24.90M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta1.02
  • YTD % Change-1.99

KEY STATS

  • Open18.31
  • Day High18.43
  • Day Low18.12
  • Prev Close18.39
  • 52 Week High28.49
  • 52 Week High Date01/26/21
  • 52 Week Low16.52
  • 52 Week Low Date08/17/21
  • Market Cap453.43M
  • Shares Out24.90M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta1.02
  • YTD % Change-1.99

RATIOS/PROFITABILITY

  • EPS (TTM)-1.19
  • P/E (TTM)-15.30
  • Fwd P/E (NTM)-12.92
  • EBITDA (MRQ)-25.663M
  • ROE (MRQ)-
  • Revenue (MRQ)29.23M
  • Gross Margin (MRQ)80.20%
  • Net Margin (MRQ)-90.94%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/24/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On AVITA Medical Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
AVITA Medical Inc., formerly AVITA Therapeutics, Inc., is a regenerative medicine company with a technology platform to address medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications. Its technology provides treatment solutions derived from the regenerative properties of a patient’s own skin. The medical devices work by preparing Spray-On Skin Cells, an autologous cellular suspension comprised of the patient’s skin cells...
Lou Panaccio
Non-Executive Chairman
Michael Perry Ph.D.
Chief Executive Officer
Kathy McGee
Chief Operating Officer
Michael Holder
Chief Financial Officer
Andrew Quick
Chief Technology Officer
Donna Shiroma J.D.
General Counsel
Address
28159 Avenue Stanford, Suite 220
Valencia, CA
91355
United States